Health Care & Life Sciences » Pharmaceuticals | Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,971
3,882
3,907
3,722
3,166
3,456
Cost of Goods Sold (COGS) incl. D&A
1,347
1,277
1,243
1,280
960
638
Gross Income
4,624
2,605
2,664
2,443
2,206
2,818
SG&A Expense
3,299
741
669
687
903
1,359
EBIT
1,325
1,918
1,906
1,816
1,303
1,459
Unusual Expense
9
-
-
4
-
163
Non Operating Income/Expense
557
33
756
103
531
583
Interest Expense
-
8
-
10
8
7
Pretax Income
1,986
2,615
3,465
2,490
1,947
2,392
Income Tax
325
489
983
552
288
394
Equity in Affiliates
9
6
41
25
47
9
Consolidated Net Income
1,653
2,120
2,522
1,963
1,705
1,989
Net Income
1,644
2,103
2,544
1,996
1,671
1,919
Net Income After Extraordinaries
1,644
2,103
2,544
1,996
1,671
1,919
Net Income Available to Common
1,644
2,103
2,544
1,996
1,671
1,919
EPS (Basic)
0.16
0.20
0.25
0.20
0.18
0.20
Basic Shares Outstanding
10,350
10,363
10,364
10,141
9,483
9,471
EPS (Diluted)
0.16
0.20
0.25
0.20
0.18
0.20
Diluted Shares Outstanding
10,350
10,363
10,364
10,141
9,483
9,471
EBITDA
1,572
2,181
2,212
2,137
1,549
1,798
Other Operating Expense
-
54
89
60
-
-
Non-Operating Interest Income
123
147
136
130
112
195
Minority Interest Expense
9
17
22
33
35
70

About Sihuan Pharmaceutical Holdings Group

View Profile
Address
21/F, Building 2
Beijing Beijing 100025
China
Employees -
Website http://www.sihuanpharm.com
Updated 07/08/2019
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It focuses on the field of cardio-cerebral vascular system, nervous system, metabolism, anti-infective, and oncology. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.